Literature DB >> 28299659

Mechanism of ETV6-RUNX1 Leukemia.

Aishwarya Sundaresh1, Owen Williams2.   

Abstract

The t(12;21)(p13;q22) translocation is the most frequently occurring single genetic abnormality in pediatric leukemia. This translocation results in the fusion of the ETV6 and RUNX1 genes. Since its discovery in the 1990s, the function of the ETV6-RUNX1 fusion gene has attracted intense interest. In this chapter, we will summarize current knowledge on the clinical significance of ETV6-RUNX1, the experimental models used to unravel its function in leukemogenesis, the identification of co-operating mutations and the mechanisms responsible for their acquisition, the function of the encoded transcription factor and finally, the future therapeutic approaches available to mitigate the associated disease.

Entities:  

Keywords:  Leukemia; Oncogene; Signalling; TEL-AML1; Transcription factor

Mesh:

Substances:

Year:  2017        PMID: 28299659     DOI: 10.1007/978-981-10-3233-2_13

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  7 in total

Review 1.  Molecular markers in ALL: Clinical implications.

Authors:  Shunsuke Kimura; Charles G Mullighan
Journal:  Best Pract Res Clin Haematol       Date:  2020-06-07       Impact factor: 3.020

2.  Reduced Dose Intensity of Daunorubicin During Remission Induction for Low-Risk Patients With Acute Lymphoblastic Leukemia: A Retrospective Cohort Study of the Chinese Children's Cancer Group.

Authors:  Yong Zhuang; Kefei Wu; Xiaofan Zhu; Jiaoyang Cai; Shaoyan Hu; Ju Gao; Hua Jiang; Xiaowen Zhai; Xin Tian; Yongjun Fang; Runming Jin; Qun Hu; Hui Jiang; Ningling Wang; Lirong Sun; Wing Kwan Leung; Minghua Yang; Kaili Pan; Xuedong Wu; Changda Liang; Shuhong Shen; Jie Yu; Xiuli Ju
Journal:  Front Oncol       Date:  2022-06-07       Impact factor: 5.738

Review 3.  The Role of ARID5B in Acute Lymphoblastic Leukemia and Beyond.

Authors:  Peiqi Wang; Yun Deng; Xinyu Yan; Jianhui Zhu; Yuanyuan Yin; Yang Shu; Ding Bai; Shouyue Zhang; Heng Xu; Xiaoxi Lu
Journal:  Front Genet       Date:  2020-06-12       Impact factor: 4.599

Review 4.  Genetic Biomarkers and Their Clinical Implications in B-Cell Acute Lymphoblastic Leukemia in Children.

Authors:  Monika Lejman; Aleksandra Chałupnik; Zuzanna Chilimoniuk; Maciej Dobosz
Journal:  Int J Mol Sci       Date:  2022-03-02       Impact factor: 5.923

Review 5.  Fusion genes as biomarkers in pediatric cancers: A review of the current state and applicability in diagnostics and personalized therapy.

Authors:  Neetha Nanoth Vellichirammal; Nagendra K Chaturvedi; Shantaram S Joshi; Donald W Coulter; Chittibabu Guda
Journal:  Cancer Lett       Date:  2020-11-25       Impact factor: 9.756

6.  RUNX-mediated growth arrest and senescence are attenuated by diverse mechanisms in cells expressing RUNX1 fusion oncoproteins.

Authors:  Gail Anderson; Nancy Mackay; Kathryn Gilroy; Jodie Hay; Gillian Borland; Alma McDonald; Margaret Bell; Siti Ayuni Hassanudin; Ewan Cameron; James C Neil; Anna Kilbey
Journal:  J Cell Biochem       Date:  2017-11-20       Impact factor: 4.429

7.  ARHGEF4 Regulates an Essential Oncogenic Program in t(12;21)-Associated Acute Lymphoblastic Leukemia.

Authors:  Clemence Virely; Luca Gasparoli; Maurizio Mangolini; Katherine Clesham; Sarah Inglott; Darren Edwards; Stuart Adams; Jack Bartram; Sujith Samarasinghe; Philip Ancliff; Ajay Vora; Jasper de Boer; Owen Williams
Journal:  Hemasphere       Date:  2020-09-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.